Get the Stockscreener App
123.95
1.54%
-1.94
After Hours:
125.78
1.83
+1.48%
Genedx Holdings Corp stock is traded at $123.95, with a volume of 311.58K.
It is down -1.54% in the last 24 hours and up +6.48% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$125.89
Open:
$125.75
24h Volume:
311.58K
Relative Volume:
0.37
Market Cap:
$3.56B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-39.86
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
-6.48%
1M Performance:
+6.48%
6M Performance:
+34.61%
1Y Performance:
+224.73%
1-Day Range:
$122.23
$126.10
1-Week Range:
$120.55
$136.00
52-Week Range:
$35.88
$136.00
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
123.95 | 3.54B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx Holdings Corp. $WGS Stake Lifted by Fred Alger Management LLC - MarketBeat
GeneDx (NASDAQ:WGS) Reaches New 1-Year HighStill a Buy? - MarketBeat
Scientech Research LLC Makes New $675,000 Investment in GeneDx Holdings Corp. $WGS - MarketBeat
Alliancebernstein L.P. Boosts Stock Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Receives $101.63 Consensus Target Price from Brokerages - MarketBeat
GeneDx stock price target raised to $140 from $120 at Piper Sandler - Investing.com Nigeria
GeneDx Holdings Corp. $WGS Shares Acquired by Polar Asset Management Partners Inc. - MarketBeat
EFG Asset Management North America Corp. Buys Shares of 11,013 GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx Holdings Corp. $WGS is Bosun Asset Management LLC's 2nd Largest Position - MarketBeat
What are the risks of holding GeneDx Holdings Corp.Recession Risk & Growth Focused Stock Pick Reports - Lancaster City Council
GeneDx Holdings Corp. $WGS Holdings Lifted by Comerica Bank - MarketBeat
GeneDx at Morgan Stanley Conference: Rare Disease Focus By Investing.com - Investing.com Canada
GeneDx Holdings Corp. Equity Warrant Moves Into Overbought Range Analysts CautiousMarket Performance Report & Fast Entry Momentum Alerts - beatles.ru
Pattern Scan Adds GeneDx Holdings Corp. Equity Warrant to WatchlistM&A Rumor & Weekly Setup with High ROI Potential - beatles.ru
GeneDx at Morgan Stanley Conference: Rare Disease Focus - Investing.com
GeneDx (NASDAQ:WGS) CFO Kevin Feeley Sells 378 Shares - MarketBeat
Momentum Traders Eye GeneDx Holdings Corp. Equity Warrant for Quick BounceJuly 2025 Intraday Action & Verified Short-Term Plans - beatles.ru
Trapped Investors in GeneDx Holdings Corp. Equity Warrant Await Breakout SignalEarnings Risk Summary & Community Trade Idea Sharing - beatles.ru
GeneDx (WGS): Valuation in Focus Following Securities Investigation Triggered by Fraud Allegations - Yahoo Finance
GeneDx (NASDAQ:WGS) Sets New 1-Year HighStill a Buy? - MarketBeat
Earnings visualization tools for GeneDx Holdings Corp.July 2025 Earnings & Safe Capital Growth Tips - Newser
GeneDx Holdings Corp. stock chart pattern explained2025 Trading Recap & Stock Portfolio Risk Control - Newser
Using economic indicators to assess GeneDx Holdings Corp. Equity Warrant potential2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
GeneDx Holdings Corp. (NASDAQ:WGS) Looks Just Right With A 25% Price Jump - 富途牛牛
Magnetar Financial LLC Invests $555,000 in GeneDx Holdings Corp. $WGS - MarketBeat
Sentiment analysis tools applied to GeneDx Holdings Corp.Trade Analysis Summary & Free High Return Stock Watch Alerts - Newser
How to build a dashboard for GeneDx Holdings Corp. Equity Warrant stockJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser
Can GeneDx Holdings Corp. disrupt its industryJuly 2025 Price Swings & Real-Time Volume Analysis - خودرو بانک
How to manage a losing position in GeneDx Holdings Corp.Market Trend Summary & Entry Point Confirmation Alerts - Newser
Statistical indicators supporting GeneDx Holdings Corp. Equity Warrant’s strengthCPI Data & Accurate Technical Buy Alerts - Newser
Can GeneDx Holdings Corp. Equity Warrant outperform in the next rallyEarnings Miss & Technical Confirmation Trade Alerts - خودرو بانک
Price momentum metrics for GeneDx Holdings Corp. Equity Warrant explained2025 Sector Review & High Yield Stock Recommendations - Newser
Will GeneDx Holdings Corp. outperform the marketEntry Point & Smart Investment Allocation Insights - Newser
Alamea Verwaltungs GmbH Purchases Shares of 211,065 GeneDx Holdings Corp. $WGS - MarketBeat
WGS Investor News: If You Have Suffered Losses in GeneDx - GlobeNewswire
How sentiment analysis helps forecast GeneDx Holdings Corp. Equity WarrantForecast Cut & Advanced Swing Trade Entry Plans - Newser
Is GeneDx Holdings Corp. a candidate for recovery play2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Will GeneDx Holdings Corp. Equity Warrant stock recover after recent dropTrade Entry Summary & Weekly Breakout Stock Alerts - Newser
GeneDx Holdings Corp. Equity Warrant stock momentum explainedQuarterly Performance Summary & Technical Buy Zone Confirmation - Newser
Relative strength of GeneDx Holdings Corp. Equity Warrant in sector analysis2025 Trading Volume Trends & Safe Entry Trade Reports - Newser
News impact scoring models applied to GeneDx Holdings Corp.Portfolio Value Summary & Stepwise Swing Trade Plans - Newser
Pittsburgh Post-Gazette - FinancialContent
GeneDx at Wells Fargo Conference: Diagnostic Ambitions - Investing.com India
Is GeneDx Holdings Corp. a turnaround storyWeekly Gains Report & Fast Gaining Stock Strategy Reports - خودرو بانک
What is the next catalyst for GeneDx Holdings Corp.July 2025 Intraday Action & Stepwise Trade Execution Plans - خودرو بانک
Is GeneDx Holdings Corp. Equity Warrant stock a smart retirement pick2025 Biggest Moves & Long-Term Safe Investment Ideas - خودرو بانک
RSI Reset May Fuel Rebound in GeneDx Holdings Corp.Buy Signal & Technical Entry and Exit Alerts - beatles.ru
Can GeneDx Holdings Corp. reach resistance levels soonJuly 2025 Sentiment & Precise Swing Trade Alerts - خودرو بانک
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):